Dr. Stefan Walzer is a renowned expert in healthcare reimbursement, payer strategy, pricing, and health economics, with a career starting in 2004.

Stefan's innovative contributions include creating the first Market Access 4.0 suite. This includes mAxInsights, an early reimbursement artificial intelligence (AI) platform, the reimbursement dossier writing AI DO-BO. Additionally, he developed the objection handling AI Q-BO which is also being implemented in the Virtual Reality platform Wafle which can be used for healthcare payer negotiations or key account and sales reps trainings. These developments highlight his commitment to advancing market access with novel technologies.

Before his entrepreneurial endeavors, Stefan developed his expertise as a global payer strategy leader at F. Hoffmann – La Roche AG and as a consultant for international pharmaceutical and medical device companies. His successful product launches worldwide reflect his adeptness at navigating complex reimbursement challenges.

Stefan is also dedicated to education, teaching market access and health technology assessment at different German universities. His academic credentials include a Master of Science in Economics from the University of Tuebingen, a PhD in Health Economics from the University of Zurich, and a Diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine.

As a scholar, Stefan has co-authored over 50 peer-reviewed scientific articles and more than 400 scientific abstracts, and he has significantly contributed to literature on reimbursement value, pricing, and digital healthcare in Germany. He also hosts the only podcast dedicated to Market Access, further extending his influence in the healthcare sector.

Through his innovative work, educational efforts, and scholarly contributions, Dr. Stefan Walzer actively shapes the future of healthcare reimbursement and market access.